Patients are beginning fertility treatment at an older age, which experts suggest could be partly down to a knock-on effect of delays from the COVID pandemic.
The average age of women starting IVF treatment for the first time has passed 35, a report by the fertility regulator says. This is six years older than the average age women in England and Wales give birth to their first child - 29 - according to official statistics. Experts believe this trend is partly down to funding issues, the cost of living and delays from the COVID pandemic.
The overall pregnancy rate from IVF using fresh embryo transfers and patient's own eggs rose from 21% per embryo transferred in 2012 to 31% in 2022. Those aged 18 to 34 had the highest pregnancy rate per embryo transferred at 42%. The majority of IVF patients in 2022 were in heterosexual relationships and accounted for 90% of the total. However, there was an 82% jump in the number of single patients undergoing IVF, from 1,953 in 2019 to 3,548 in 2022.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Proportion of NHS-funded IVF cycles lowest since 2008, says fertility regulatorMeanwhile, the average age of first-time IVF patients passed 35 for the first time in 2022.
Read more »
Cornwall dentist where Rishi Sunak announced recovery plan drops all adult NHS patientsA dentist in Cornwall which was visited by Rishi Sunak has now dropped all NHS adult patients.
Read more »
Why junior doctors’ strike during hot weather is a nightmare for NHS and patients90 per cent of hospital buildings are vulnerable to overheating - with some wards exceeding 30ºC even when it's around 20°C outside
Read more »
NHS weight-loss services turning away new patients due to Ozempic demandExperts have said the rise in obesity and the demand for weight-loss injections, such as Ozempic and Wegovy, may be fuelling the increase in referrals
Read more »
Blood cancer patients fear relapse after NHS watchdog withdraws vital treatmentIsaPD has been shown to improve remissions by over 12 months but it have been rejected by Nice for use in the NHS in England due to its cost
Read more »
NHS withdrawal of vital treatment raises relapse fears for blood cancer patientsIsaPD has been shown to improve remissions by over 12 months but it have been rejected by Nice for use in the NHS in England due to its cost
Read more »